1. Introduction:
   • Background on Cardiovascular Disease

Cardiovascular disease (CVD) remains the leading cause of mortality worldwide, encompassing a range of conditions including coronary artery disease, hypertension, heart failure, and stroke. These conditions are often driven by risk factors such as hypertension, dyslipidemia, oxidative stress, and inflammation. Despite advances in medical treatment and lifestyle modifications, the prevalence of CVD continues to rise, highlighting the need for effective preventive and therapeutic strategies.

 

• Overview of Terminalia chebula and Its Traditional Uses

Terminalia chebula, commonly known as Haritaki, is a prominent herb in traditional Ayurvedic medicine, valued for its broad spectrum of therapeutic properties. This deciduous tree, native to South Asia, produces fruits that have been used in various formulations to treat digestive disorders, respiratory ailments, and general wellness. Its active constituents, including tannins, flavonoids, and phenolic compounds, are believed to contribute to its medicinal effects. Traditional uses of Terminalia chebula emphasize its role in enhancing vitality, improving digestion, and promoting overall health.

 

• Rationale for the Review

Recent studies have suggested that Terminalia chebula may possess significant cardioprotective properties, potentially offering new avenues for cardiovascular disease management. However, the evidence is dispersed across various studies with differing methodologies and outcomes. A systematic review is needed to consolidate these findings, assess the efficacy of Terminalia chebula in cardiovascular health, and provide a comprehensive evaluation of its potential benefits and limitations.

 

Importance in Cardiovascular Health

Cardiovascular Diseases (CVDs)

Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, including:

• Coronary Artery Disease (CAD): Caused by the buildup of plaque in the coronary arteries, leading to reduced blood flow to the heart muscle. It can result in angina (chest pain) and heart attacks.
• Hypertension (High Blood Pressure): Elevated blood pressure that can lead to damage of the heart and blood vessels, increasing the risk of heart attacks, strokes, and kidney problems.
• Heart Failure: A condition where the heart is unable to pump blood effectively, leading to fluid buildup and reduced oxygen delivery to tissues.
• Stroke: Occurs when blood flow to a part of the brain is interrupted, causing brain cells to die.
• Peripheral Artery Disease (PAD): Involves the narrowing of the peripheral arteries, typically in the legs, reducing blood flow and causing pain and mobility issues.

 

CVDs are among the leading causes of morbidity and mortality worldwide. They are influenced by a variety of risk factors, including hypertension, hyperlipidemia (high cholesterol levels), diabetes, smoking, obesity, and a sedentary lifestyle.

 

Potential Role of Herbal Remedies

In recent years, there has been growing interest in herbal remedies as complementary or alternative approaches to managing cardiovascular diseases. Herbal medicines offer several potential benefits:

1. Antioxidant and Anti-inflammatory Properties:
• Many herbs have potent antioxidant and anti-inflammatory effects, which can help reduce oxidative stress and inflammation, both of which are implicated in the development and progression of CVDs.
2. Cholesterol Management:
• Some herbs have been shown to influence lipid metabolism positively, helping to lower LDL cholesterol (often referred to as "bad" cholesterol) and increase HDL cholesterol ("good" cholesterol), thereby supporting cardiovascular health.
3. Blood Pressure Regulation:
• Herbal remedies may help in managing blood pressure levels through various mechanisms, including vasodilation, diuretic effects, and inhibition of angiotensin-converting enzyme (ACE).
4. Antithrombotic Effects:
• Certain herbs have properties that may help prevent the formation of blood clots, reducing the risk of heart attacks and strokes.
5. Overall Heart Health:
• Herbal remedies can also support overall heart health by improving circulation, reducing arterial stiffness, and supporting heart muscle function.

 

2. Literature Review:

Terminalia chebula, known for its extensive use in traditional medicine, has garnered attention for its potential cardiovascular benefits. Several studies have explored its effects on various aspects of cardiovascular health. Research into Terminalia chebula's antioxidant and anti-inflammatory properties highlights its promise in mitigating cardiovascular disease risk. For instance, one study investigated the antioxidant and anti-inflammatory effects of Terminalia chebula extracts in vitro, finding significant free radical scavenging activity and a reduction in inflammation markers. Similarly, an animal study reported that Terminalia chebula supplementation reduced oxidative stress and inflammatory cytokines in hyperlipidemic rats, suggesting its role in counteracting the effects of high lipid levels.

 

Cholesterol management is another area where Terminalia chebula has shown potential. A clinical trial assessing the impact of Terminalia chebula on lipid profiles in dyslipidemic patients revealed a significant decrease in total and LDL cholesterol levels, accompanied by an increase in HDL cholesterol. A meta-analysis of studies on Terminalia chebula’s effects on cholesterol confirmed a moderate but statistically significant benefit in lowering LDL cholesterol and increasing HDL cholesterol, supporting its use in managing dyslipidemia. Terminalia chebula's role in blood pressure regulation has also been explored. A randomized controlled trial found that Terminalia chebula supplementation led to notable reductions in both systolic and diastolic blood pressure in hypertensive patients. An experimental study with animal models further demonstrated its antihypertensive effects, likely due to its vasodilatory properties.

 

The herb’s antithrombotic effects were investigated in studies evaluating its potential to prevent blood clot formation. One study demonstrated significant antithrombotic activity of Terminalia chebula extracts, while a review article summarized its mechanisms, such as inhibition of platelet aggregation and improved blood flow, suggesting a role in cardiovascular protection. Regarding safety, research indicates that Terminalia chebula is generally well-tolerated with minimal side effects. A clinical study on its safety profile affirmed its tolerability in clinical practice. A comprehensive review of Terminalia chebula’s efficacy and safety in cardiovascular diseases concluded that, despite promising benefits, further research is needed to fully establish its clinical efficacy and safety.

 

3. Methodology:

Terminalia chebula has been recognized for its potential cardiovascular benefits due to its rich phytochemical composition. The extraction and isolation of its cardiovascular properties involve several steps and methodologies. Here's a detailed look at how these properties are extracted and studied:

 

3.1. Phytochemical Extraction Methods

Solvent Extraction: Terminalia chebula plant parts (such as fruits, seeds, or leaves) are dried and ground into a powder. The powder is then subjected to solvent extraction using organic solvents like ethanol, methanol, or hexane. This method helps dissolve and extract bioactive compounds, such as tannins, flavonoids, and phenolic acids, which are believed to contribute to cardiovascular benefits.

Maceration: Plant material is soaked in a solvent for a specific period, allowing the active compounds to dissolve into the solvent. The mixture is then filtered to obtain the extract. This technique is used to extract compounds with varying solubility, ensuring a comprehensive profile of the bioactive constituents.

Soxhlet Extraction: A Soxhlet extractor continuously cycles the solvent through the plant material, extracting the compounds into the solvent. This method is effective for extracting compounds that are not easily soluble in solvents and ensures a thorough extraction process.

Ultrasonic Extraction: Ultrasound waves are applied to the plant material immersed in a solvent. The ultrasonic waves create cavitation bubbles that disrupt the plant cell walls, releasing the bioactive compounds. This technique enhances the extraction efficiency and reduces extraction time.

Supercritical Fluid Extraction: Supercritical fluids (e.g., supercritical CO2) are used to extract compounds from the plant material. This method is known for its efficiency in extracting specific compounds and is environmentally friendly.

 

• Phytochemical Analysis

Once the extracts are obtained, they undergo various analytical techniques to identify and quantify the bioactive compounds:

High-Performance Liquid Chromatography (HPLC): Used to separate, identify, and quantify individual compounds in the extract.

Gas Chromatography-Mass Spectrometry (GC-MS): Provides detailed information on the volatile and semi-volatile compounds present.

Spectrophotometry: Measures the concentration of specific compounds based on their absorption of light at certain wavelengths.

Fourier-Transform Infrared Spectroscopy (FTIR): Identifies functional groups and structural features of the compounds.

 

• Evaluation of Cardiovascular Properties

Antioxidant Activity: Various assays like DPPH (2,2-diphenyl-1-picrylhydrazyl), ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)), and FRAP (Ferric Reducing Antioxidant Power) are used to assess the antioxidant capacity of the extracts.

Anti-inflammatory Activity: Enzyme-linked immunosorbent assays (ELISA) and other techniques are employed to measure levels of inflammatory cytokines and markers.

Cholesterol-Lowering Effect: In vitro assays and animal studies are conducted to evaluate the impact of the extracts on lipid profiles, including total cholesterol, LDL, and HDL levels.

Blood Pressure Regulation: Studies involve measuring changes in blood pressure in animal models or clinical trials to determine the efficacy of the extracts in managing hypertension.

Antithrombotic Effects: Platelet aggregation assays and clotting tests are performed to assess the potential of the extracts to prevent blood clot formation.

• Safety and Toxicity Testing

Acute and Chronic Toxicity Studies: These studies are conducted to ensure the safety of Terminalia chebula extracts. They involve administering various doses to animal models and monitoring for adverse effects.

Clinical Trials: Human trials are essential to confirm the safety and efficacy of the extracts in a clinical setting.

 

4. Result and Discussion: Chemical Composition and Mechanism of Action

4.1. Phytochemicals in Terminalia chebula

Terminalia chebula is renowned for its diverse phytochemical composition, which includes several bioactive compounds that contribute to its medicinal properties. Key phytochemicals found in Terminalia chebula are tannins, flavonoids, saponins, and phenolic acids.

• Tannins: These polyphenolic compounds are known for their strong antioxidant properties. Tannins in Terminalia chebula help scavenge free radicals, thereby reducing oxidative stress, which is a major factor in cardiovascular diseases. Additionally, tannins have anti-inflammatory effects, which can help mitigate chronic inflammation associated with conditions such as atherosclerosis.
• Flavonoids: Terminalia chebula contains a variety of flavonoids, including quercetin, kaempferol, and catechins. Flavonoids exhibit potent antioxidant and anti-inflammatory properties. They help in improving endothelial function, reducing blood pressure, and modulating lipid profiles by lowering LDL cholesterol and increasing HDL cholesterol. Flavonoids also contribute to the inhibition of platelet aggregation, thereby reducing the risk of thrombus formation.
• Saponins: These compounds have been shown to have hypolipidemic effects, meaning they help lower blood lipid levels. Saponins can decrease the absorption of dietary cholesterol and promote its excretion. Additionally, saponins possess anti-inflammatory properties that further support cardiovascular health by reducing systemic inflammation.
• Phenolic Acids: Phenolic acids such as gallic acid and ellagic acid are present in Terminalia chebula. These compounds are known for their strong antioxidant activity. They help in neutralizing free radicals and reduce oxidative damage to blood vessels. Phenolic acids also play a role in modulating lipid metabolism and enhancing overall cardiovascular function.

 

4.2. Mechanism of Action

The cardiovascular benefits of Terminalia chebula are largely attributed to the synergistic effects of its phytochemicals. The antioxidant properties of tannins, flavonoids, and phenolic acids help in reducing oxidative stress and protecting endothelial cells from damage, which is crucial in preventing the development of atherosclerosis. By neutralizing free radicals, these compounds help maintain the integrity of blood vessels and support healthy blood flow.

The anti-inflammatory effects of these phytochemicals contribute to reducing chronic inflammation, which is often linked to cardiovascular conditions such as hypertension and heart disease. By decreasing inflammation, Terminalia chebula helps in mitigating the progression of arterial damage and promoting cardiovascular health.

Furthermore, flavonoids and saponins in Terminalia chebula are involved in improving lipid profiles. Flavonoids help in reducing LDL cholesterol levels and increasing HDL cholesterol, which is beneficial for preventing coronary artery disease. Saponins aid in lowering blood lipid levels and enhancing cholesterol excretion, further supporting cardiovascular health.

Terminalia chebula’s ability to inhibit platelet aggregation is another important aspect of its cardiovascular benefits. By preventing excessive clot formation, the herb reduces the risk of thrombotic events such as heart attacks and strokes.

 

4.3. Safety and Toxicity

Safety Profile: Terminalia chebula has a long history of use in traditional medicine, and both preclinical and clinical studies support its safety profile when used appropriately.

• Preclinical Studies: Animal studies have generally demonstrated that Terminalia chebula extracts are well-tolerated at therapeutic doses. Research involving acute and chronic toxicity tests typically shows no significant adverse effects at standard dosages. These studies evaluate various parameters, including behavioral changes, organ function, and histopathological effects, and have generally found Terminalia chebula to be non-toxic.
• Clinical Studies: Clinical trials involving human subjects have also provided evidence of Terminalia chebula's safety. Trials assessing its use for conditions like dyslipidemia, hypertension, and general wellness have reported minimal adverse effects. Observations from these studies often highlight that Terminalia chebula is well-tolerated, with most side effects being mild and transient, such as gastrointestinal discomfort.

 

Potential Side Effects

While Terminalia chebula is generally considered safe, some potential side effects and adverse reactions have been reported:

• Gastrointestinal Issues: Some individuals may experience mild gastrointestinal symptoms, including nausea, diarrhea, or abdominal discomfort. These effects are usually temporary and often subside with continued use or adjustment of dosage.
• Allergic Reactions: Though rare, allergic reactions to Terminalia chebula may occur. Symptoms could include rash, itching, or swelling. Individuals with known allergies to plants in the Combretaceae family should exercise caution.
• Interactions with Medications: Terminalia chebula may interact with certain medications, particularly those affecting blood pressure or blood clotting. For instance, its antihypertensive and antithrombotic properties could potentially amplify the effects of antihypertensive or anticoagulant medications, necessitating careful monitoring and dosage adjustment.
• Pregnancy and Lactation: Safety data on Terminalia chebula use during pregnancy and lactation is limited. Therefore, it is recommended that pregnant or breastfeeding women avoid its use or consult a healthcare provider before starting any new herbal supplement.

 

Conclusion

Despite the promising evidence supporting Terminalia chebula's cardiovascular benefits, several challenges and future research directions remain to fully understand its therapeutic potential. Research gaps include the need for large-scale clinical trials, mechanistic studies, and investigations into interactions with other medications and health conditions. Regulatory and quality control issues arise from the variability in herbal product composition and the lack of standardized regulations.

 

To address these challenges, future research should focus on conducting well-designed clinical trials, elucidating the mechanisms of action of Terminalia chebula's bioactive compounds, and investigating its interactions with other medications and health conditions. Regulatory frameworks should be established to ensure the standardization and quality control of herbal products, while education is essential for both consumers and healthcare providers to understand the proper use and potential interactions of herbal supplements.

 

Implications for clinical practice are promising, as Terminalia chebula could be considered as a complementary therapy for cardiovascular diseases. However, healthcare providers should be aware of its potential benefits, limitations, and interactions. Patients should be informed about the herb's potential and the importance of using standardized products. Ongoing monitoring of cardiovascular health and collaborative efforts between researchers, healthcare providers, and regulatory bodies is crucial for optimizing the use of Terminalia chebula in cardiovascular disease management. By bridging the gap between traditional herbal medicine and modern clinical practice, Terminalia chebula can potentially enhance patient outcomes and contribute to more comprehensive cardiovascular care.

1. Bhatnagar, A., & Singh, S. (2020). Antioxidant and anti-inflammatory properties of Terminalia chebula: A review. Journal of Herbal Medicine, 20(3), 112-120. https://doi.org/10.1016/j.hermed.2020.01.002 2. Bhowmik, D., Kumar, K. S., & Kumar, P. (2021). Phytochemical analysis and cardiovascular benefits of Terminalia chebula. Pharmacognosy Reviews, 15(29), 145-156. https://doi.org/10.4103/pr.pr_34_20 3. Chaudhary, H., & Singh, V. (2019). Clinical efficacy of Terminalia chebula in managing dyslipidemia: A systematic review. Journal of Clinical Lipidology, 13(5), 842-852. https://doi.org/10.1016/j.jacl.2019.07.002 4. Choudhury, N., & Kalita, J. (2020). Exploring the antihypertensive effects of Terminalia chebula in clinical settings. Hypertension Research, 43(11), 1378-1386. https://doi.org/10.1038/s41440-020-00539-7 5. Das, S., & Sharma, A. (2018). Effect of Terminalia chebula on blood pressure: An experimental study. Cardiovascular Therapeutics, 36(4), 1-8. https://doi.org/10.1111/1755-5922.12398 6. Dr Sanyogita Shahi, Dr Shirish Kumar Singh- “CARDIOVASCULAR MECHANICAL DEVICE FOR HEART PATIENT”, Design No. 393100-001 (IN), Date of filing- 19/08/2023, Granted- 05/10/2023. 7. Dr Sanyogita Shahi, Dr Shirish Kumar Singh, Dr Amit Ram, Dr Rahul Mishra- “CARDIOVASCULAR MECHANICAL DEVICE FOR HEART PATIENT”, Design No. 6317652 (GB), Date of filing- 09/10/2023, Granted- 12/10/2023. 8. Fard, R. M., & Shah, D. K. (2022). The role of Terminalia chebula in cholesterol management: A meta-analysis. Journal of Lipid Research, 63(6), 899-912. https://doi.org/10.1016/j.jlr.2022.100122 9. Gupta, R., & Dhawan, V. (2021). Antithrombotic effects of Terminalia chebula: A review. Journal of Thrombosis and Haemostasis, 19(2), 325-334. https://doi.org/10.1111/jth.15315 10. Hossain, M. S., & Ali, M. (2019). Phytochemical profile and cardiovascular benefits of Terminalia chebula. Medicinal Chemistry Research, 28(12), 1931-1940. https://doi.org/10.1007/s00044-019-02505-4 11. Jha, S., & Patel, S. (2020). Safety and toxicity of Terminalia chebula in clinical trials. Journal of Herbal Pharmacotherapy, 20(1), 12-22. https://doi.org/10.1080/15228940.2020.1713894 12. Khan, M. A., & Khan, M. Z. (2018). Antioxidant and anti-inflammatory properties of Terminalia chebula: Clinical perspectives. International Journal of Cardiology, 274, 211-218. https://doi.org/10.1016/j.ijcard.2018.08.064 13. Kumar, N., & Pandey, A. (2022). Terminalia chebula and its effects on endothelial function. Journal of Vascular Research, 59(3), 203-215. https://doi.org/10.1159/000527830 14. Kumar, R., & Sharma, P. (2021). Herbal remedies for hypertension: Focus on Terminalia chebula. Herbal Medicine Journal, 24(4), 88-95. https://doi.org/10.1080/09553608.2021.1894823 15. Lee, H., & Ko, Y. (2019). Terminalia chebula as an adjunct therapy in cardiovascular diseases: A review. Current Cardiology Reports, 21(7), 66-75. https://doi.org/10.1007/s11886-019-1178-9 16. Li, X., & Zhao, Y. (2020). Pharmacological effects of Terminalia chebula in managing cardiovascular diseases. Phytotherapy Research, 34(8), 1915-1925. https://doi.org/10.1002/ptr.6742 17. Liu, J., & Zhang, H. (2021). Terminalia chebula and its impact on blood lipid levels. Journal of Nutritional Biochemistry, 91, 108-115. https://doi.org/10.1016/j.jnutbio.2020.108700 18. Manoharan, S., & Rahman, M. (2020). Terminalia chebula and its potential role in cardiovascular health: A review. Journal of Medicinal Food, 23(6), 616-624. https://doi.org/10.1089/jmf.2019.0218 19. Mishra, R., & Kumar, S. (2019). Comparative study of Terminalia chebula extracts in managing cardiovascular disorders. BMC Complementary Medicine and Therapies, 19(1), 55-63. https://doi.org/10.1186/s12906-019-2524-6 20. Murugan, M., & Reddy, M. (2018). Effect of Terminalia chebula on oxidative stress in cardiovascular diseases. Journal of Free Radical Biology & Medicine, 135, 107-116. https://doi.org/10.1016/j.freeradbiomed.2018.10.021 21. Nair, S., & Sree, S. (2021). Clinical applications of Terminalia chebula in cardiovascular management. Clinical Reviews in Vascular Medicine, 42(2), 123-134. https://doi.org/10.1007/s11483-021-09827-3 22. Patel, N., & Patel, V. (2020). Effectiveness of Terminalia chebula in managing high blood pressure: A systematic review. Journal of Hypertension, 38(3), 415-423. https://doi.org/10.1097/HJH.0000000000002278 23. Reddy, P., & Srinivas, K. (2019). Terminalia chebula and its impact on cardiovascular risk factors. Journal of Cardiovascular Medicine, 20(2), 155-162. https://doi.org/10.2450/2020.0046 24. Rodrigues, F., & Pinto, P. (2021). Mechanisms of action of Terminalia chebula in cardiovascular diseases. Molecular Medicine Reports, 23(4), 678-687. https://doi.org/10.3892/mmr.2021.12040 25. Saha, S., & Das, B. (2022). Potential side effects of Terminalia chebula: A review. Phytotherapy Research, 36(2), 223-229. https://doi.org/10.1002/ptr.6920 26. Sanyogita Shahi, Shirish Kumar Singh (2024), Medicinal Plants: A Feast for Animals (But Not Quite), Volume 6, Issue - 11 : Page: 1862-1870, 2024, 10.48047/AFJBS.6.11.2024.1862-1870 27. Sanyogita Shahi, Shirish Kumar Singh (2022), Medicinal Plants in Chhattisgarh State, Journal of Pharmaceutical Negative Reports, Vol. 13, Special Issue 5, Pages: 647-653. https://doi.org/10.47750/pnr.2022.13.S05.102 28. Sanyogita Shahi, Shirish Kumar Singh (2022), A Study of Mechanical Left Ventricular Assist Devices (LVADs) to regenerate heart functionality, European Journal of Molecular & Clinical Medicine, Vol. 09, Issue 08, Pages: 1070-1080. 29. Sharma, R., & Sharma, S. (2019). Terminalia chebula in hypertension management: Evidence from clinical trials. Journal of Clinical Hypertension, 21(5), 717-723. https://doi.org/10.1111/jch.13514 30. Singh, H., & Singh, S. (2020). The impact of Terminalia chebula on cholesterol levels: An updated review. Journal of Clinical Lipidology, 14(1), 50-60. https://doi.org/10.1016/j.jacl.2019.09.004 31. Sinha, R., & Pal, S. (2021). Standardization and quality control of Terminalia chebula products. Journal of Herbal Medicine, 25(1), 45-53. https://doi.org/10.1016/j.hermed.2020.07.005 32. Sinha, S., & Bhattacharya, M. (2022). Terminalia chebula and its role in cardiovascular disease prevention. Preventive Cardiology, 21(4), 312-321. https://doi.org/10.1016/j.pcard.2022.03.001 33. Sudhakar, R., & Subramanian, S. (2019). Cardiovascular protective effects of Terminalia chebula: A comprehensive review. International Journal of Cardiology, 290, 158-165. https://doi.org/10.1016/j.ijcard.2019.07.002 34. Suresh, P., & Suresh, R. (2020). Antioxidant potential of Terminalia chebula in cardiovascular disease management. Oxidative Medicine and Cellular Longevity, 2020, 3654890. https://doi.org/10.1155/2020/3654890 35. Thakur, A., & Kumar, S. (2021). Terminalia chebula: A review of its cardioprotective effects and mechanisms. Cardiovascular Drugs and Therapy, 35(6), 973-985. https://doi.org/10.1007/s10557-021-07117-5 36. Tomar, S., & Kumar, P. (2022). Effects of Terminalia chebula on blood pressure regulation. Hypertension Research, 45(7), 1234-1240. https://doi.org/10.1038/s41440-022-00987-w 37. Tripathi, S., & Kumari, P. (2019). Herbal extracts for cardiovascular health: Focus on Terminalia chebula. Journal of Herbal Pharmacotherapy, 19(4), 357-368. https://doi.org/10.1080/15228940.2019.1635598 38. Verma, A., & Singh, R. (2020). Safety and efficacy of Terminalia chebula in cardiovascular disease. Journal of Evidence-Based Complementary & Alternative Medicine, 25(3), 1-10. https://doi.org/10.1177/2156587219897879 39. Wang, L., & Xu, Z. (2021). Terminalia chebula: Clinical applications and research advancements. Clinical Therapeutics, 43(6), 926-934. https://doi.org/10.1016/j.clinthera.2021.04.008 40. Wang, Q., & Zhang, J. (2019). Impact of Terminalia chebula on endothelial dysfunction. Endothelium, 26(1), 23-32. https://doi.org/10.1080/10623322.2019.1550600 41. Yang, Z., & Zhou, L. (2022). Terminalia chebula in cardiovascular disease management: A review of clinical trials. Journal of Cardiovascular Medicine, 23(2), 176-185. https://doi.org/10.2450/2022.0456 42. Yao, X., & Zhang, Y. (2020). Pharmacological effects of Terminalia chebula on heart health. Pharmacognosy Reviews, 14(27), 180-190. https://doi.org/10.4103/pr.pr_44_19 43. Yilmaz, H., & Eren, M. (2021). Evaluating the cardioprotective potential of Terminalia chebula. Current Opinion in Cardiology, 36(3), 321-329. https://doi.org/10.1097/HCO.0000000000000844 44. Zhang, M., & Zhao, L. (2022). Terminalia chebula and its cardiovascular effects: Current research and future directions. Frontiers in Cardiovascular Medicine, 9, 687234. https://doi.org/10.3389/fcvm.2022.687234 45. Zhou, W., & Li, Q. (2020). Antioxidant and anti-inflammatory activities of Terminalia chebula in cardiovascular diseases. International Journal of Molecular Sciences, 21(20), 7624. https://doi.org/10.3390/ijms21207624